Psoralen photochemotherapy of cutaneous disorders.
D002273:Carcinogens; D002386:Cataract / Q000139:chemically induced; D002462:Cell Membrane / Q000502:physiology; D004247:DNA / Q000502:physiology; D004890:Erythema / Q000188:drug therapy; D011564:Furocoumarins / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D049673:History, 20th Century; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008214:Lymphocytes / Q000502:physiology; D008543:Melanins / Q000502:physiology; D010778:Photochemotherapy / Q000266:history; D011506:Proteins / Q000502:physiology; D012313:RNA / Q000502:physiology; D012871:Skin Diseases / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects; D014467:Ultraviolet Therapy
D002273:Carcinogens; D011564:Furocoumarins; D008543:Melanins; D011506:Proteins; D012313:RNA; D004247:DNA